Full Text View
Tabular View
No Study Results Posted
Related Studies
N-Acetyltransferase 2 (NAT2) Genotyping in re-Challenge of Isoniazid (INH) in Patients With Antituberculous (Anti-TB) Medications-Induced Hepatitis
This study is currently recruiting participants.
Study NCT00728546   Information provided by National Taiwan University Hospital
First Received: August 1, 2008   Last Updated: August 5, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Tuberculosis
Hepatotoxicity
Additional conditions recognized in this trial
Hepatitis
More general conditions related to this trial
Actinomycetales Infections
Bacterial Infections
Digestive System Diseases
Gram-Positive Bacterial Infections
Liver Diseases
Mycobacterium Infections
Interventions listed in this trial
Isoniazid (Rifinah)
Additional drug interventions recognized in this trial
Isoniazid
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Antilipemic Agents
Antimetabolites
Antitubercular Agents
Fatty Acid Synthesis Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
National Taiwan University Hospital
Department of Health, Taiwan


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services